Franklin Resources Inc. Has $3.16 Million Stock Position in Addus HomeCare Co. (NASDAQ:ADUS)

Franklin Resources Inc. cut its stake in Addus HomeCare Co. (NASDAQ:ADUS) by 3.8% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 25,214 shares of the company’s stock after selling 1,002 shares during the period. Franklin Resources Inc. owned about 0.14% of Addus HomeCare worth $3,161,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also modified their holdings of ADUS. Smartleaf Asset Management LLC lifted its holdings in shares of Addus HomeCare by 324.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 280 shares of the company’s stock valued at $35,000 after acquiring an additional 214 shares during the period. Parkside Financial Bank & Trust lifted its holdings in Addus HomeCare by 38.6% during the 4th quarter. Parkside Financial Bank & Trust now owns 531 shares of the company’s stock valued at $67,000 after purchasing an additional 148 shares during the last quarter. Meeder Asset Management Inc. bought a new position in Addus HomeCare during the 4th quarter valued at about $77,000. Harvest Fund Management Co. Ltd bought a new stake in Addus HomeCare during the fourth quarter worth about $86,000. Finally, KBC Group NV increased its holdings in shares of Addus HomeCare by 49.1% during the fourth quarter. KBC Group NV now owns 814 shares of the company’s stock worth $102,000 after buying an additional 268 shares in the last quarter. Institutional investors own 95.35% of the company’s stock.

Analysts Set New Price Targets

ADUS has been the topic of several recent analyst reports. Oppenheimer boosted their target price on Addus HomeCare from $145.00 to $150.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. Stephens restated an “overweight” rating and set a $142.00 target price on shares of Addus HomeCare in a report on Wednesday, March 12th. Citizens Jmp upgraded Addus HomeCare to a “strong-buy” rating in a research note on Monday, December 16th. Macquarie reissued an “outperform” rating and set a $129.00 price objective on shares of Addus HomeCare in a report on Thursday, February 27th. Finally, JMP Securities restated a “market outperform” rating and issued a $150.00 price objective on shares of Addus HomeCare in a research report on Thursday. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating, seven have assigned a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $132.78.

Addus HomeCare Stock Down 0.9 %

Shares of Addus HomeCare stock opened at $100.85 on Friday. Addus HomeCare Co. has a 12-month low of $87.88 and a 12-month high of $136.72. The business’s 50 day moving average is $101.16 and its 200-day moving average is $118.07. The stock has a market cap of $1.83 billion, a P/E ratio of 23.08, a P/E/G ratio of 1.41 and a beta of 0.93.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings results on Monday, February 24th. The company reported $1.26 EPS for the quarter, missing analysts’ consensus estimates of $1.35 by ($0.09). The firm had revenue of $297.14 million during the quarter, compared to analyst estimates of $291.04 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. On average, sell-side analysts expect that Addus HomeCare Co. will post 4.59 EPS for the current year.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.